Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.
|Articles|May 19, 2011
DSM Makes Moves in Green Biotechnology
At a plenary session of the 2011 World Congress on Industry Biotechnology and Bio-Processing, held in Toronto, Feike Sijbesma, CEO of Royal DSM N.V. (Heerlen, Netherlands), received the George Washington Carver Award for innovation in industrial biotechnology.
Advertisement
At a plenary session of the 2011 World Congress on Industry Biotechnology and Bio-Processing, held in Toronto, Feike Sijbesma, CEO of Royal DSM N.V. (Heerlen, Netherlands), received the George Washington Carver Award for innovation in industrial biotechnology.
In his keynote address, Sijbesma spoke of the potential for biotechnology to revolutionize modern culture through providing food and energy from plant materials. An excerpt from his speech has been preserved in its original form:
Biotechnology of the future can possibly allow us to produce from plant materials, both human food, by extracting nutritional high quality human food proteins, as well as biomaterials, bio-chemicals and bioenergy (fuels and gas).
DSM also announced a new partnership with Roquette Fréres (Lestrem, France) to begin
Advertisement
Related to this article
Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.
The company says the innovation, built on its CoreNhanced BioJourney platform, is designed for beverage and gummy formats.
AuraFen, BILVORA, and IMBE debut at SupplySide Global 2026, and the company will also highlight its CaFi digestive health ingredient.
Horphag Research's Sébastien Bornet breaks down the clinical science behind Robuvit, exploring how the caffeine-free French oak extract supports mitochondrial energy, mood stability, and stress resilience.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
The company plans to present Organicaps capsules in size 0, 25 years of UC-II, and liquid-filled capsule technology.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Navigating Supplement Ingredients and Claims Regulations in Europe, the US, and Canada
2
FDA Finalizes NDI Guidance on Identity and Safety Information, Leaving Some Industry Concerns Open
3
Thirty Years of GCP: The Evolution From Study Execution to Evidence Generation
4
CoreFX Launches CreaSHLD-IN Shielded Creatine at SupplySide Global 2026
5